The Enterprise Value as of December 2025 (TTM) for Arno Therapeutics, Inc. (ARNI) is 2.04M

According to Arno Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.04M. This represents a change of -84.36% compared to the average of 13.01M of the last 4 quarters.

Arno Therapeutics, Inc. (ARNI) Historical Enterprise Value (quarterly & annually)

How has ARNI Enterprise Value performed in the past?

The mean historical Enterprise Value of Arno Therapeutics, Inc. over the last ten years is 14.13M. The current 2.04M Enterprise Value has changed 1.34% with respect to the historical average. Over the past ten years (40 quarters), ARNI's Enterprise Value was at its highest in in the December 2008 quarter at 56.20M. The Enterprise Value was at its lowest in in the December 2010 quarter at -3118311.76.

Arno Therapeutics, Inc. (ARNI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arno Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arno Therapeutics, Inc. (ARNI) Average Enterprise Value

How has ARNI Enterprise Value performed in the past?

The current Enterprise Value of Arno Therapeutics, Inc. (ARNI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Arno Therapeutics, Inc. (ARNI) Enterprise Value vs. Peers

How is ARNI’s Enterprise Value compared to its peers?

Arno Therapeutics, Inc.’s Enterprise Value is greater than Panacos Pharmaceuticals, Inc. (-18548633.00), greater than Calithera Biosciences, Inc. (-23784025.00), less than TetraLogic Pharmaceuticals Corporation (12.98M), greater than Innovation1 Biotech Inc. (183.64K), greater than Better Therapeutics, Inc. (-854548.00), greater than Oncology Pharma Inc. (767.67K), greater than Baudax Bio, Inc. (1.86M), greater than Kaleido Biosciences, Inc. (-16566887.00), greater than Ampio Pharmaceuticals, Inc. (-3809096.00), less than Tengion, Inc. (5.45M),

Build a custom stock screener for Arno Therapeutics, Inc. (ARNI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arno Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arno Therapeutics, Inc. (ARNI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arno Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.